Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
European Journal of Immunology|February 3, 2007
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patientsAndrea De Maria, Manuela Fogli, Stefania Mazza, et al.Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.Journal of Clinical Microbiology|March 30, 2002
Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosisClaudio Viscoli, Marco Machetti, Paola Gazzola, et al.International Immunology|January 11, 2011
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruptionFederica Bozzano, Milena Nasi, Linda Bertoncelli, et al.AIDS (London, England)|January 25, 2003
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patientsPaola Costa, Stefano Rusconi, Manuela Fogli, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activationBarbara Morandi, Roberta Costa, Michela Falco, et al.Surgical Infections|May 10, 2012
Breast implant infections after surgical reconstruction in patients with breast cancer: assessment of risk factors and pathogens over extended post-operative observationSimonetta Franchelli, Francesca Vassallo, Claudia Porzio, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infectionRoberto Biassoni, Manuela Fogli, Claudia Cantoni, et al.Frontiers in Immunology|August 16, 2024
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodiesMargherita Bellucci, Federica Maria Bozzano, Chiara Castellano, et al.Anticancer Research|July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancerAlessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.Pageof 11